Kingfisher Soars, Roche's Shot, Ericsson's Slip | Stock Movers

By Bloomberg Podcasts

Community Score: 50% | 4 views | 3w

0 community ratings: null thumbs up, null thumbs down

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Kingfisher shares rise as much as 11%, the most in a year, after the B&Q and Screwfix owner posted a first-half earnings beat and lifted its full-year profit guidance beyond analyst expectations. - Roche Holding’s experimental obesity shot enicepatide cut both blood sugar and body weight in type-2 diabetes patients who were overweight or obese in a mid-stage trial. - Ericsson slips as much as 3.9%, the most since mid July, after Morgan Stanley downgrades the Swedish mobile networks and technology group to underweight from equal-weight, saying margins are “inflecting to the downside.” See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information. Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street. Check out more episodes of Stock Movers: https://www.youtube.com/playlist?lis

Tags: Business, Business News, Daily News, News, bloomberg, bloomberg news, business, finance, investing, investing news, markets, markets news, podcast, radio, stock, stock market, stocks, stocks podcast

More from Bloomberg Podcasts

  • Follow the Money All the Way to Carney's Canada — Score: 50%
  • Daybreak Weekend: US CPI, Europe Energy, RBA Decision | Bloomberg Daybreak: Europe Edition — Score: 50%
  • Bloomberg Money: Credit Card Indicators and Golf's Changing Fanbase | Bloomberg Intelligence — Score: 50%
  • We hear you! | Bloomberg Hot Pursuit! — Score: 50%
  • Bloomberg Businessweek Weekend - August 7th, 2026 | Bloomberg Businessweek — Score: 50%
  • Team Favorite: AI-Era Internet, Spaceport Investment, Bolivia’s Investability | Wall Street Week — Score: 50%